The new offering, part of the ELEOS Limb Salvage System, is designed to support bone ingrowth in musculoskeletal oncology and complex orthopaedic limb salvage cases.
Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in...
Neo received 510(k) clearance and approval under the CE Mark for the system plus BonOs Inject cement from OSARTIS in an advanced stage tumor indication.